Global /India /Healthcare /Drug Manufacturers - General /531015

Venmax Drugs and Pharmaceuticals Ltd.

531015 (VENMAX)

• BSE: 531015 • Delayed

25.52INR 2.4%

0.2703 USD

As of 21 June 2026, Venmax Drugs and Pharmaceuticals Ltd. has a market cap of $3.13M USD, ranking #46080 globally and #4250 in India. It ranks #4090 in the Healthcare sector, and #1309 in the Drug Manufacturers - General industry.

Global Rank

46080

Country Rank

4250

Sector Rank

4090

Industry Rank

1309

Key Stats

Market Cap

$3.13MUSD

295.6M INR

Enterprise Value

$3.33MUSD

314.53M INR

Revenue (TTM)

$467.65KUSD

44.14M INR

EBITDA (TTM)

-$17.67KUSD

-1.67M INR

Net Income (TTM)

$92.42KUSD

8.72M INR

EBITDA Margin

-3.8%

Profit Margin

20%

PE Ratio

18.6

PS Ratio

6.7

PB Ratio

3.1

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Nooka Krishnaiah open_in_new

Employees

Founded

1988

Website

venmaxdrugs.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.4%	-6.9%	-3.7%	4.3%	-12%	-0.1%	-5.9%	381%	381%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	531015 (VENMAX) Venmax Drugs & Pharmaceuticals Ltd ISIN: INE154G01022 TV: TradingView: BSE: VENMAX SA: Stock Analysis: BOM: 531015 YF: Yahoo Finance: 531015.BO GF: Google Finance: BOM: 531015 BA: Barron's: 531015 MS: Morningstar: XBOM: 531015	25.52 INR	TV: TradingView: BSE: VENMAX SA: Stock Analysis: BOM: 531015 YF: Yahoo Finance: 531015.BO GF: Google Finance: BOM: 531015 BA: Barron's: 531015 MS: Morningstar: XBOM: 531015

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Venmax Drugs and Pharmaceuticals Ltd.

Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API’s. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 1M%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 587K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 484K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 375K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 315K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 310K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 24M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 17M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 12M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 10M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 9M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 9M%	15.1	United States

chevron_leftBack